The global NMN Capsule market size is predicted to grow from US$ 440 million in 2025 to US$ 837 million in 2031; it is expected to grow at a CAGR of 11.3% from 2025 to 2031.

NMN, the full name of ?-nicotinamide mononucleotide (Nicotinamide Mononucleotide), is a naturally occurring nucleotide with a chemical formula of C11H15N2O8P. It is the direct precursor of nicotinamide adenine dinucleotide (NAD+) and can be converted into NAD+ in the human body, thereby participating in a variety of biological processes, including energy metabolism, DNA repair, and cell signaling. With the increase of age, the content of NMN in the human body gradually decreases, so NMN is often used as an anti-aging nutritional supplement. As the market continues to expand, governments and relevant agencies will increase their supervision of the market and formulate more complete laws, regulations and standards systems to protect consumer rights and market order. For example, Japan is the first country in the world to approve NMN as a food ingredient, while the US FDA lists NMN as a GRAS (generally recognized as safe) dietary supplement ingredient. The NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving birth to a series of innovative products and service models. This cross-border integration not only enriches the product line of the NMN market, but also enhances its market competitiveness. Although the NMN market has broad prospects, it also faces challenges such as the proliferation of counterfeit and inferior products and exaggerated publicity that weakens consumer confidence. However, with the continuous advancement of technology and the standardized development of the market, the NMN market is expected to usher in a broader development prospect.

Competition among brands in the market is becoming increasingly fierce, requiring companies to continue to innovate to maintain their competitive advantage. At the same time, improving consumers awareness and trust in NMN products is also the key to the continued development of the market. GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Effex Pharmaceuticals, Kingdomway, etc. are the worlds leading manufacturers of nicotinamide mononucleotide. Worldwide, North America, China, and Japan are the main manufacturing regions. China is the leader in the nicotinamide mononucleotide market, and its revenue will account for 70% of the global market share in 2023.

Infinity Market Research newest research report, the NMN Capsule Industry Forecast looks at past sales and reviews total world NMN Capsule sales in 2024, providing a comprehensive analysis by region and market sector of projected NMN Capsule sales for 2025 through 2031. With NMN Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NMN Capsule industry.

This Insight Report provides a comprehensive analysis of the global NMN Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NMN Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global NMN Capsule market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NMN Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NMN Capsule.

This report presents a comprehensive overview, market shares, and growth opportunities of NMN Capsule market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Content ?98%
    Content ?98%

Segmentation by Application:

    Health Care Products
    Cosmetics
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Herbalmax
    Mirailab Bioscience
    Maac10 Formulas
    GeneHarbor
    EffePharm
    Genex Formulas
    Bontac
    CELFULL
    Kingdomway

Key Questions Addressed in this Report

What is the 10-year outlook for the global NMN Capsule market?
What factors are driving NMN Capsule market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NMN Capsule market opportunities vary by end market size?
How does NMN Capsule break out by Type, by Application?